الدين تغيير تاريخ
AbbVie USD 70.82B 2.04B 2026-06
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amarin USD 0 0 2025-03
AstraZeneca USD 32.24B 1.68B 2026-06
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
DBV Technologies USD 7.5M 1.4M 2026-09
GlaxoSmithKline GBP 18.24B 818M 2026-06
Halozyme Therapeutics USD 2.15B 2.02M 2026-06
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Novartis USD 49.01B 2.02B 2026-06